SCHEMBL26175977

SCHEMBL26175977

FC(F)Oc1ccc2c(-c3cc4ccncc4s3)c[nH]c2n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DYRK1A Q13627 4/20 0.41
▸ CDK5 Q00535 3/20 0.41
▸ CLK1 P49759 2/20 0.41
▸ CLK2 P49760 2/20 0.41
▸ CLK4 Q9HAZ1 2/20 0.41
▸ DYRK1B Q9Y463 2/20 0.41
▸ CLK3 P49761 1/20 0.41
▸ CDK5R1 Q15078 1/20 0.41
▸ CYP2A6 P11509 2/20 0.35
▸ AKT1 P31749 3/20 0.35
▸ PIM1 P11309 3/20 0.35
▸ CDK2 P24941 2/20 0.35
▸ CHEK1 O14757 2/20 0.35
▸ DAPK3 O43293 2/20 0.35
▸ PAK4 O96013 2/20 0.35
▸ FGFR1 P11362 2/20 0.35
▸ PRKACA P17612 2/20 0.35
▸ FLT1 P17948 2/20 0.35
▸ KDR P35968 2/20 0.35
▸ MAPK8 P45983 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26175940 0.85 DYRK1A (0.58) DYRK1ACDK5CLK1CLK2CLK4
SCHEMBL26176018 0.83 DYRK1A (0.44) DYRK1ACDK5CLK1CLK2CLK4
SCHEMBL26175737 0.79 TGFBR1 (0.43) DYRK1ACDK5CLK1CLK2CLK4
SCHEMBL26175678 0.79 CYP2A6 (0.40) DYRK1ACDK5CLK1CLK2CLK4
SCHEMBL26174486 0.77 TGFBR1 (0.53) DYRK1ACDK5CLK1CLK2CLK4
SCHEMBL26176055 0.76 CYP2A6 (0.40) DYRK1ACDK5CLK1CLK2CLK4
SCHEMBL26175776 0.76 DYRK1A (0.37) DYRK1ACDK5CLK1CLK2CLK4
SCHEMBL26176262 0.76 HASPIN (0.43) DYRK1ACDK5CLK1CLK2CLK4
SCHEMBL26175860 0.74 DYRK1A (0.36) DYRK1ACDK5CLK1CLK2CLK4
SCHEMBL26174697 0.74 CLK1 (0.53) DYRK1ACLK1CLK2CLK4DYRK1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230192686-A1 1H-PYRROLO[2,3-B]PYRIDINES AND PREPARATION AND USES THEREOF TENARX, INC. 2023-06-22 — — US disclosed
US-20230192686-A1 1H-PYRROLO[2,3-B]PYRIDINES AND PREPARATION AND USES THEREOF TENARX, INC. 2023-06-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230192686-A1 1H-PYRROLO[2,3-B]PYRIDINES AND PREPARATION AND USES THEREOF DYRK1A, DYRK1B, DYRK2 DYRK1A 1/4885CDK5 83/4885CLK1 268/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback